Clinical Trials in Zossen, Germany
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
Eosinophilic Asthma
AstraZeneca400 enrolled157 locationsNCT06750289
Recruiting
A Non-interventional, Prospective Study With Benralizumab
Asthma, Bronchial
AstraZeneca300 enrolled41 locationsNCT06422078